We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPA
2576
DELISTED
Sparton
SPA
| $230K | ﹤0.01% |
9,957
-1,744
| -15% | -$40.5K |
|
2577
Ardelyx
ARDX
$1.25B
| $229K | ﹤0.01% |
34,681
-6,575
| -16% | -$39K |
|
|
RC
2578
Ready Capital
RC
$261M
| $229K | ﹤0.01% |
15,114
-3,024
| -17% | -$47.5K |
|
2579
Home Bancorp
HBCP
$558M
| $228K | ﹤0.01% |
5,274
-1,092
| -17% | -$46.1K |
|
|
CMRX
2580
DELISTED
Chimerix, Inc.
CMRX
| $227K | ﹤0.01% |
49,021
| – | – |
|
|
LAYN
2581
DELISTED
Layne Christensen Co
LAYN
| $226K | ﹤0.01% |
18,017
-3,652
| -17% | -$46.8K |
|
2582
Rush Enterprises Class B
RUSHB
$6.07B
| $225K | ﹤0.01% |
10,523
-1,775
| -14% | -$36.6K |
|
|
BCOV
2583
DELISTED
Brightcove, Inc.
BCOV
| $225K | ﹤0.01% |
31,626
-6,060
| -16% | -$43.9K |
|
|
QTNA
2584
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $225K | ﹤0.01% |
18,409
-3,774
| -17% | -$51.6K |
|
|
BSTC
2585
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $223K | ﹤0.01% |
5,158
-1,619
| -24% | -$72.8K |
|
2586
Acacia Research
ACTG
$426M
| $220K | ﹤0.01% |
54,241
-9,000
| -14% | -$38.1K |
|
2587
Sportsman's Warehouse
SPWH
$45.3M
| $219K | ﹤0.01% |
33,205
-6,467
| -16% | -$31K |
|
|
NPTN
2588
DELISTED
NEOPHOTONICS CORP
NPTN
| $219K | ﹤0.01% |
33,310
-5,344
| -14% | -$32.6K |
|
|
TRHC
2589
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $218K | ﹤0.01% |
7,778
-1,665
| -18% | -$48.8K |
|
|
BREW
2590
DELISTED
Craft Brew Alliance, Inc.
BREW
| $218K | ﹤0.01% |
11,342
-1,776
| -14% | -$33.3K |
|
2591
DHI Group
DHX
$176M
| $216K | ﹤0.01% |
113,795
+20,616
| +22% | +$42.7K |
|
|
AC
2592
DELISTED
Associated Capital Group
AC
| $215K | ﹤0.01% |
6,351
-902
| -12% | -$31.9K |
|
|
BLCM
2593
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $215K | ﹤0.01% |
2,555
-518
| -17% | -$50.8K |
|
|
RST
2594
DELISTED
ROSETTA STONE INC
RST
| $214K | ﹤0.01% |
17,152
-3,510
| -17% | -$39.2K |
|
2595
Kura Oncology
KURA
$826M
| $213K | ﹤0.01% |
13,935
-910
| -6% | -$13.4K |
|
2596
Oil-Dri
ODC
$1.42B
| $213K | ﹤0.01% |
10,260
-1,814
| -15% | -$39.8K |
|
2597
Village Super Market
VLGEA
$651M
| $213K | ﹤0.01% |
9,293
-1,290
| -12% | -$31.1K |
|
|
ECOM
2598
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $213K | ﹤0.01% |
23,689
-4,499
| -16% | -$44.5K |
|
|
SREV
2599
DELISTED
ServiceSource International, Inc.
SREV
| $213K | ﹤0.01% |
69,040
-13,541
| -16% | -$43.5K |
|
|
SRGA
2600
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $213K | ﹤0.01% |
1,735
-342
| -16% | -$47K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.